105 related articles for article (PubMed ID: 15650451)
1. Phase I clinical trial of targeted therapy using 131I-Hepama-1 mAb in patients with hepatocellular carcinoma.
Chen S; Li B; Xie H; Xu L; Niu G; Fan K; Fan Q
Cancer Biother Radiopharm; 2004 Oct; 19(5):589-600. PubMed ID: 15650451
[TBL] [Abstract][Full Text] [Related]
2. Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131I-anti-HCC mAb. Phase I/II clinical trials.
Zeng ZC; Tang ZY; Liu KD; Lu JZ; Xie H; Yao Z
J Cancer Res Clin Oncol; 1998; 124(5):275-80. PubMed ID: 9645459
[TBL] [Abstract][Full Text] [Related]
3. Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131I-labeled Hepama-1 mAb. Preliminary results and discussion.
Zeng ZC; Tang ZY; Liu KD; Lu JZ; Cai XJ; Xie H
Cancer Immunol Immunother; 1994 Nov; 39(5):332-6. PubMed ID: 7987865
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy for unresectable hepatocellular carcinoma using 131I-Hepama-1 mAb: preliminary results.
Zeng ZC; Tang ZY; Xie H; Liu KD; Lu JZ; Chai XJ; Wang GF; Yao Z; Qian JM
J Cancer Res Clin Oncol; 1993; 119(5):257-9. PubMed ID: 8382704
[TBL] [Abstract][Full Text] [Related]
5. Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma.
Zeng ZC; Tang ZY; Yang BH; Liu KD; Wu ZQ; Fan J; Qin LX; Sun HC; Zhou J; Jiang GL
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1657-68. PubMed ID: 12458401
[TBL] [Abstract][Full Text] [Related]
6. [Radioimmunologic targeting and therapy with antihuman primary hepatic cancer monoclonal antibodies (Hepama I) in patients].
Shi L; Wu M; Chen H
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):146-9. PubMed ID: 10743083
[TBL] [Abstract][Full Text] [Related]
7. [Radioimmunoimaging (RII) and radioimmunotherapy (RIT) of human primary hepatic cancer (hPHC) with anti-PHC monoclonal antibody in tumor bearing nude mice].
Shi L; Wu M; Chen H
Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):20-3. PubMed ID: 7656780
[TBL] [Abstract][Full Text] [Related]
8. [Clinical value of iodine [131I] metuximab infusion combined with TACE for treatment of patients with post-intervention relapse of mid or advanced stage hepatocellular carcinoma].
Li Z; Zhou JX; Ren JZ; Zhang WJ; Han XW
Zhonghua Gan Zang Bing Za Zhi; 2013 Oct; 21(10):728-33. PubMed ID: 24331628
[TBL] [Abstract][Full Text] [Related]
9. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials.
Chen ZN; Mi L; Xu J; Song F; Zhang Q; Zhang Z; Xing JL; Bian HJ; Jiang JL; Wang XH; Shang P; Qian AR; Zhang SH; Li L; Li Y; Feng Q; Yu XL; Feng Y; Yang XM; Tian R; Wu ZB; Leng N; Mo TS; Kuang AR; Tan TZ; Li YC; Liang DR; Lu WS; Miao J; Xu GH; Zhang ZH; Nan KJ; Han J; Liu QG; Zhang HX; Zhu P
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):435-44. PubMed ID: 16690431
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
[TBL] [Abstract][Full Text] [Related]
11. [Antibody-targeted radio-chemotherapy of human primary liver cancer with radio-iodinated AFP monoclonal antibodies conjugated with mitomycin C: a preliminary clinical observation].
Li Z; Wu Y; Zhou D
Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):368-71. PubMed ID: 9387278
[TBL] [Abstract][Full Text] [Related]
12. Enhanced radioimmunotherapeutic efficacy of a monoclonal antibody cocktail against SMMC-7721 human hepatocellular carcinoma.
Song YQ; Wang GF; Dai XL; Xie H
Cell Res; 1998 Sep; 8(3):241-7. PubMed ID: 9791737
[TBL] [Abstract][Full Text] [Related]
13. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
[TBL] [Abstract][Full Text] [Related]
14. Optimal timing of administration of hyperthermia in combined radioimmunotherapy.
Kinuya S; Yokoyama K; Hiramatsu T; Konishi S; Watanabe N; Shuke N; Aburano T; Bunko H; Michigishi T; Tonami N
Cancer Biother Radiopharm; 2000 Aug; 15(4):373-9. PubMed ID: 11041022
[TBL] [Abstract][Full Text] [Related]
15. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma.
Sundram F; Chau TC; Onkhuudai P; Bernal P; Padhy AK
Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):250-7. PubMed ID: 15129708
[TBL] [Abstract][Full Text] [Related]
16. Radioiodine gene therapy of hepatocellular carcinoma targeted human alpha fetoprotein.
Jin YN; Chung HK; Kang JH; Lee YJ; Kimm KI; Kim YJ; Kim S; Chung JK
Cancer Biother Radiopharm; 2008 Oct; 23(5):551-60. PubMed ID: 18986218
[TBL] [Abstract][Full Text] [Related]
17. [The experimental study of anti-human AFP variant McAb in radioimmuno-detection and radioimmuno-therapy of human hepatocellular carcinoma model in nude mice].
Liu Y; Wu MC; Qian GX
Zhonghua Wai Ke Za Zhi; 1994 Nov; 32(11):650-3. PubMed ID: 7539734
[TBL] [Abstract][Full Text] [Related]
18. Prospects of radioimmunotherapy in epithelial ovarian cancer: results with iodine-131-labeled murine and humanized MN-14 anti-carcinoembryonic antigen monoclonal antibodies.
Juweid M; Swayne LC; Sharkey RM; Dunn R; Rubin AD; Herskovic T; Goldenberg DM
Gynecol Oncol; 1997 Dec; 67(3):259-71. PubMed ID: 9441773
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of 131I-chimeric(ch) TNT-1/B monoclonal antibody for the treatment of advanced colon cancer.
Street HH; Goris ML; Fisher GA; Wessels BW; Cho C; Hernandez C; Zhu HJ; Zhang Y; Nangiana JS; Shan JS; Roberts K; Knox SJ
Cancer Biother Radiopharm; 2006 Jun; 21(3):243-56. PubMed ID: 16918301
[TBL] [Abstract][Full Text] [Related]
20. Combined radioimmunotherapy and radiotherapy of liver metastases from colorectal cancer: a feasibility study.
Buchegger F; Allal AS; Roth A; Papazyan JP; Dupertuis Y; Mirimanoff RO; Gillet M; Pelegrin A; Mach JP; Slosman DO
Anticancer Res; 2000; 20(3B):1889-96. PubMed ID: 10928122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
